We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.92%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$223B
AUM Growth
+$132B
Cap. Flow
+$128B
Cap. Flow %
57.4%
Top 10 Hldgs %
41.38%
Holding
5,646
New
798
Increased
2,634
Reduced
1,094
Closed
385

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.5B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TSLA icon
Tesla
TSLA
+$951M
4
JNJ icon
Johnson & Johnson
JNJ
+$750M
5
UNH icon
UnitedHealth
UNH
+$703M

Sector Composition

Rank Sector Weight
1 Technology 12.48%
2 Healthcare 7.36%
3 Financials 6.5%
4 Consumer Discretionary 5.35%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
4026
Immunic
IMUX
$190M
$111K ﹤0.01%
+7,937
New +$216K
CIX icon
4027
Comp X International
CIX
$349M
$111K ﹤0.01%
6,009
+361
+6% +$6.71K
FIRY
4028
Firy Inc
FIRY
$148M
$111K ﹤0.01%
10,912
+3,553
+48% +$65.3K
BTAI icon
4029
BioXcel Therapeutics
BTAI
$24.9M
$110K ﹤0.01%
321
+270
+529% +$65.3K
NLY icon
4030
PUT
Annaly Capital Management
NLY
$17.1B
$110K ﹤0.01%
+5,200
New +$102K
AIH
4031
DELISTED
Aesthetic Medical International Holdings
AIH
$109K ﹤0.01%
84,754
IPVI
4032
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$109K ﹤0.01%
10,723
GIL icon
4033
Gildan
GIL
$10.3B
$109K ﹤0.01%
3,986
-43,082
-92% -$1.25M
PUCK
4034
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$109K ﹤0.01%
10,850
XPOF icon
4035
Xponential Fitness
XPOF
$273M
$109K ﹤0.01%
4,756
+4,020
+546% +$82.9K
INST
4036
DELISTED
Instructure Holdings, Inc.
INST
$109K ﹤0.01%
4,647
+3,913
+533% +$91.3K
PVBC
4037
DELISTED
Provident Bancorp
PVBC
$109K ﹤0.01%
14,942
+3,261
+28% +$33.1K
DHR.PRB
4038
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
$109K ﹤0.01%
+80
New +$108K
HIFS icon
4039
Hingham Institution for Saving
HIFS
$627M
$108K ﹤0.01%
393
+331
+534% +$87.2K
MCBS icon
4040
MetroCity Bankshares
MCBS
$1.01B
$108K ﹤0.01%
5,013
+4,102
+450% +$89.2K
GATO
4041
DELISTED
Gatos Silver, Inc.
GATO
$108K ﹤0.01%
+26,392
New +$95.9K
UI icon
4042
Ubiquiti
UI
$33.7B
$108K ﹤0.01%
394
-398
-50% -$118K
NGVC icon
4043
Vitamin Cottage Natural Grocers
NGVC
$739M
$107K ﹤0.01%
11,734
+2,097
+22% +$22.1K
DM
4044
DELISTED
Desktop Metal, Inc.
DM
$107K ﹤0.01%
7,864
+6,077
+340% +$127K
LUCK
4045
Lucky Strike Entertainment
LUCK
$914M
$107K ﹤0.01%
7,931
+6,218
+363% +$84.2K
MNDY icon
4046
monday.com
MNDY
$3.68B
$107K ﹤0.01%
876
-5,195
-86% -$540K
CDRE icon
4047
Cadre Holdings
CDRE
$1.32B
$107K ﹤0.01%
5,295
+4,310
+438% +$111K
DRVN icon
4048
Driven Brands
DRVN
$2.35B
$107K ﹤0.01%
3,903
-15,797
-80% -$472K
VBK icon
4049
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$106K ﹤0.01%
530
CARE icon
4050
Carter Bankshares
CARE
$766M
$106K ﹤0.01%
6,400
+5,307
+486% +$93K

Similar funds

Barclays's Q4 2022 Portfolio in Review

As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.

  • Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
  • Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
  • Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
  • Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
  • Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
  • Barclays opened 798 new positions and closed 385 in Q4 2022.
  • Barclays's portfolio value rose 144% quarter-over-quarter to $223B.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.